Ritonavir | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ritonavir
Australia

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

Contact Supplier

pharmacompass-1-m-2025-11-24

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

pharmacompass-2-m-2025-11-03

Ritonavir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 24 USDMF, 12 CEP/COS, 1 JDMF, 9 EU WC, 3 KDMF, 9 NDC API, 27 Listed Suppliers, $ API Reference Price

51 API Suppliers
24 USDMF
12 CEP/COS
1 JDMF
9 EU WC
3 KDMF
9 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

343 Drugs in Development

343 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

135 FDF Dossiers, 41 FDA Orange Book, 42 Europe, 7 Canada, 5 Australia, 25 South Africa, 15 Listed Dossiers

135 FDF Dossiers
41 FDA Orange Book
42 Europe
7 Canada
5 Australia
25 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 100MG;25MG, TABLET;ORAL - 200MG;50MG, TABLET;ORAL - 100MG

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 100MG;25MG
TABLET;ORAL - 200MG;50MG
TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 1 SPI Pharma, 10 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 6 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 5 Kirsch Pharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 2 Bioplus Life Sciences, 1 CD Formulation, 1 Clariant, 12 Corel Pharma Chem, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 11 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 3 Roquette, 15 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Sigachi Industries, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 34 Solubilizers, 30 Fillers, Diluents & Binders, 26 Parenteral, 20 Topical, 20 Film Formers & Plasticizers, 19 Controlled & Modified Release, 18 Thickeners and Stabilizers, 17 Emulsifying Agents, 13 Taste Masking, 12 Direct Compression, 12 Lubricants & Glidants, 11 Granulation, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Disintegrants & Superdisintegrants, 5 Rheology Modifiers, 5 Co-Processed Excipients, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Chewable & Orodispersible Aids

46 Coating Systems & Additives
34 Solubilizers
30 Fillers, Diluents & Binders
26 Parenteral
20 Topical
20 Film Formers & Plasticizers
19 Controlled & Modified Release
18 Thickeners and Stabilizers
17 Emulsifying Agents
13 Taste Masking
12 Direct Compression
12 Lubricants & Glidants
11 Granulation
10 API Stability Enhancers
9 Empty Capsules
8 Surfactant & Foaming Agents
5 Disintegrants & Superdisintegrants
5 Rheology Modifiers
5 Co-Processed Excipients
4 Vegetarian Capsules
4 Coloring Agents
2 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 156 News #PharmaBuzz

2 Data Compilation #PharmaFlow
2 Stock Recap #PipelineProspector
156 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 10 Regulatory FDF Prices, 18 Annual Reports

11 US Medicaid Prescriptions
10 Regulatory FDF Prices
18 Annual Reports

MARKET PLACE

25 APIs, 9 FDF Dossiers

25 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

27 US Patents, 57 Health Canada Patents

27 US Patents
57 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 Others

2 EDQM
3 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 499 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 3AbbVie Pty Ltd

02 2Pfizer Australia Pty Ltd

filter Active Ingredients Reset all filters

5 All

01 2Lopinavir + ritonavir

02 1Ritonavir

03 2nirmatrelvir (&) ritonavir

filter Dosage Form Reset all filters

5 All

01 1Solution; Solution

02 3Tablet; Tablet

03 1tablet

filter Brand Name Reset all filters

5 All

01 2Kaletra

02 1Norvir

03 2Paxlovid

List of Suppliers

Product Main Page

01

AbbVie Pty Ltd

ISPOR Europe 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Australia

Lopinavir + ritonavir

Brand Name : Kaletra

Dosage Form : Tablet; Tablet

Dosage Strength : 200MG; 50MG

Packaging : 120

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AbbVie Pty Ltd

ISPOR Europe 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Australia

Brand Name : Norvir

Dosage Form : tablet

Dosage Strength : 100MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AbbVie Pty Ltd

ISPOR Europe 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Australia

Lopinavir + ritonavir

Brand Name : Kaletra

Dosage Form : Solution; Solution

Dosage Strength : 80MG/1ML; 20MG/1ML

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Pfizer Australia Pty Ltd

ISPOR Europe 2025

Not Confirmed

Pfizer Australia Pty Ltd

ISPOR Europe 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

nirmatrelvir (&) ritonavir

Brand Name : Paxlovid

Dosage Form : Tablet; Tablet

Dosage Strength : 150MG; 100MG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Pfizer Australia Pty Ltd

ISPOR Europe 2025

Not Confirmed

Pfizer Australia Pty Ltd

ISPOR Europe 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

nirmatrelvir (&) ritonavir

Brand Name : Paxlovid

Dosage Form : Tablet; Tablet

Dosage Strength : 150MG; 100MG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!